Flavonoids as Inhibitors of MRP1-Like Efflux Activity in Human Erythrocytes. A Structure-Activity Relationship Study

Oncology Research

Volumn 13, Issue 11, 2002, Pages 463-469

  Bobrowska Hägerstrand, Małgorzata ^a   Wróbel, Anna ^b   Mrówczyñska, Lucyna ^c   Söderström, Thomas ^a,d   Shirataki, Yoshiaki ^e   Motohashi, Noboru ^f   Molnár, Joseph ^g   Michalak, Krystyna ^h   Hägerstrand, Henry ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^c ADAM MICKIEWICZ UNIVERSITY   (Poland)

^d UNIVERSITY OF TURKU   (Finland)

^e JOSAI UNIVERSITY   (Japan)

^f MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^g UNIVERSITY OF SZEGED   (Hungary)

^h WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

BCPCF; Benzbromarone; Flavanone; Indomethacin; Multidrug resistance; Red blood cell; Structure activity analysis

Indexed keywords

2',7' BIS(CARBOXYPROPYL) 5(6) CARBOXYFLUORESCEIN; BENZBROMARONE; CARBOXYFLUORESCEIN; EUCHRESTAFLAVANONE A; FLAVANONE; FLAVONOID; GENISTEIN; INDOMETACIN; MEMBRANE LIPID; MULTIDRUG RESISTANCE PROTEIN 1; SOPHORAFLAVANONE H; STILBENE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL FUNCTION; CELL TYPE; CHEMICAL STRUCTURE; ENZYME SUBSTRATE; ERYTHROCYTE MEMBRANE; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; MULTIDRUG RESISTANCE; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN TRANSPORT; STRUCTURE ACTIVITY RELATION;

EID: 0842348982     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000003108747983     Document Type: Article

References (49)

1. Pulaski, L.; Jedlitschky, G.; Leier, I.; Buchholz, U.; Keppler, D. Identification of the multidrug-resistance protein (MRP) as the glutathione-S-conjugate export pump of erythrocytes. Eur. J. Biochem. 241:644-648; 1996.
2. Keppler. D.; Leier, I.; Jedlitschky, G. Transport of glutathione conjugates and glucorunides by the multidrug resistance proteins MRP1 and MRP2. Biol. Chem. 378:787-791; 1997.
3. Rappa, G.; Lorico, A.; Flavell, R. A.; Sartorelli, A. C. Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res. 57:5232-5237; 1997.
4. Borst, P.; Evers, R.; Kool, M.; Wijnholds, J. A family of drug transporters: The multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92:1295-1302; 2000.
5. Leslie, E. M.; Deeley, R. G.; Cole, S. P. Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 167:3-23; 2001.
6. Leslie, E. M.; Mao, Q.; Oleschuk, C. J.; Deeley, R. G.; Cole, S. P. Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATPase activities by interaction with dietary flavonoids. Mol. Pharmacol. 59: 1171-1180; 2001.
7. Borst, P.; Elferink, R. O. Mammalian abc transporters in health and disease. Annu. Rev. Biochem. 71:537-592; 2002.
8. Dekkers, D. W.; Comfurius, P.; Schroit, A. J.; Bevers, E. M.; Zwaal, R. F. Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: Outward-directed transport by the multidrug resistance protein 1 (MRP1). Biochemistry 37:14833-14837; 1998.
9. Dekkers, D. W.; Comfurius. P.; Van Gool, R. G.; Bevers, E. M.; Zwaal, R. F. Multidrug resistance protein 1 regulates lipid asymmetry in erythrocyte membranes. Biochem. J. 350:531-535; 2000.
10. Kamp, D.; Haest, C. W. M. Evidence for a role of the multidrug resistance protein (MRP) in the outward translocation of NBD-phospholipids in the erythrocyte membrane. Biochim. Biophys. Acta 1372:91-101; 1998.
11. Borst, P.; Zelcer, N.; van Helvoort. A. ABC transporters in lipid transport. Biochim. Biophys. Acta 1486:128-144; 2000.
12. Rychlik, B.; Pulaski, L.; Sokal, A.; Soszynski, M.; Bartosz, G. Transport of organic anions by multidrug resistance-associated protein in the erythrocytes. Acta Biochim. Pol. 47:763-772; 2000.
13. Klokouzas, A.; Barrand, M. A.; Hladky, S. B. Effects of clotrimazole on transport mediated by multidrug resistance associated protein 1 (MRP1) in human erythrocytes and tumour cells. Eur. J. Biochem. 268:6569-6577; 2001.
14. Abraham, E. H.; Sterling, K. M.; Kim, R. J.; Salikhova, A. Y.; Huffman, H. B.; Crockett. M. A.; Johnston, N.; Parker, H. W.; Boyle, W. E., Jr.; Hartov, A.; Demidenko, E.; Efird, J.; Kahn, J.; Grubman, S. A.; Jefferson, D. M.; Robson, S. C.; Thakar, J. H.; Lorico, A.; Rappa, G.; Sartorelli, A. C.; Okunieff, P. Erythrocyte membrane ATP binding cassette (ABC) proteins: MRP1 and CFTR as well as CD39 (ecto-apyrase) involved in RBC ATP transport and elevated blood plasma ATP of cystic fibrosis. Blood Cells Mol. Dis. 27:165-180; 2001.
15. Bobrowska-Hägerstrand, M.; Wróbel, A.; Rychlik, B.; Bartosz, G.; Söderström, T.; Shirataki, Y.; Motohashi, N.; Molnár, J.; Michalak, K.; Hägerstrand, H. Monitoring of MRP-like activity in human erythrocytes-inhibitory effect of isoflavones. Blood Cells Mol. Dis. 27: 894-900; 2001.
16. Shirataki, Y.; Motohashi, N.; Tani, S.; Sakagami, H.; Satoh, K.; Nakashima, H.; Mahapatra, S. K.; Ganguly, K.; Dastidar, S. G.; Chakrabarty, A. N. In vitro biological activity of prenylflavanones. Anticancer Res. 21: 275-280; 2001.
17. Shirataki, Y.; Tani, S.; Sakagami, H.; Satoh, K.; Nakashima, H.; Gotoh, K.; Motohashi, N. Relationship between cytotoxic activity and radical intensity of isoflavones from Sophora species. Anticancer Res. 21:2643-2648; 2001.
18. Beutler, E.; West, C.; Blume, K.-G. The removal of leukocytes and platelets from whole blood. J. Lab. Clin. Med. 88:328-333; 1976.
19. Mosior, M.; Bobrowska, M.; Gomulkiewicz, J. Effect of the level of ATP and of the state of spectrin on osmotic properties of bovine erythrocytes. Biochim. Biophys. Acta 1022:355-360; 1990.
20. Lutz, H. U.; Liu, S. C.; Palek, J. Release of spectrin-free vesicles from human erythrocytes during ATP depletion. I. Characterization of spectrin-free vesicles. J. Cell Biol. 73:548-560; 1977.
21. Isomaa, B.; Hägerstrand, H.; Paatero, G. Shape transformations induced by amphiphiles in erythrocytes. Biochim. Biophys. Acta 899:93-103; 1987.
22. Hägerstrand, H.; Holmström, T.; Bobrowska-Hägerstrand, M. ; Eriksson, J.; Isomaa, B. Amphiphile-induced phosphatidylserine exposure in human erythrocytes. Mol. Membr. Biol. 15:89-95; 1998.
23. Hollo, Z.; Homolya, L.; Hegedus, T.; Sarkadi, B. Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells. FEBS Lett. 383:99-104; 1996.
24. Ferte, J.; Kuhnel, J. M.; Chapuis, G.; Rolland, Y.; Lewin, G.; Schwaller, M. A. Flavonoid-related modulators of multidrug resistance: Synthesis, pharmacological activity, and structure-activity relationships. J. Med. Chem. 42:478-489; 1999.
25. Comte, G.; Daskiewicz, J-B.; Bayet, Ch.; Conseil, G.; Viomery-Vanier, A. ; Dumontet, Ch.; Di Pietro, A.; Barron, D. C-isoprenylation of flavonoids enhances binding affinity toward P-glycoprotein and modulation of cancer cell chemoresistance. J. Med. Chem. 44:763-768; 2001.
26. Hooijberg, J. H.; Broxterman, H. J.; Scheffer, G. L.; Vrasdonk, C.; Heijn, M.; de Jong, M. C.; Scheper, R. J.; Lankelma, J.; Pinedo, H. M. Potent interaction of flavopiridol with MRP1. Br. J. Cancer 81:269-276; 1999.
27. van Acker, S. A. B. E.; de Groot, M. J.; van den Berg, D.-J.; Tromp, M. N. J. L.; den Kelder. G. D.-O.; van der Vijgh, W. J. F.; Bast, A. A quantum chemical explanation of the antioxidant activity of flavonoids. Chem. Res. Toxicol. 9:1305-312; 1996.
28. Lemańska, K.; Szymusiak, H.; Tyrakowska, B.; Zieliński, R. ; Soffers, A. E. M. F.; Rietjens, I. M. C. M. The influence of pH on antioxidant properties and the mechanism of antioxidant action of hydroxyflavones. Free Radic. Biol. Med. 31:869-881; 2001.
29. Rice-Evans, C. A.; Miller, N. J.; Paganga, G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 20:933-956; 1996.
30. Dastidar, S. G.; Mahapatra, S. K.; Ganguly, K.; Chakrabarty, A. N.; Shirataki, Y.; Motohashi, N. Antimicrobial activity of prenylflavanones. In Vivo 15:519-524; 2001.
31. DiPietro, P. A.; Conseil, G.; Perez-Victoria, J. M.; Dayan. G.; Baubichon-Cortaya, H.; Trompiera, D.; Steinfels, E.; Jault, J. M. de Wet, H.; Maitrejean, M.; Comte, G.; Boumendjel, A.; Mariotte, A. M.; Dumontet, C.; McIntosh, D. B.; Goffeau, A.; Castanys, S.; Gamarro, F.; Barron, D. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cell. Mol. Life Sci. 59:307-322; 2002.
32. Tashiro, M.; Suzuki, F.; Shirataki, Y.; Yokote, Y.; Akahane, K.; Motohashi, N.; Ishihara, M.; Jiang, Y.; Sakagami, H. Effects of prenylflavanones from Sophora species on growth and activation of mouse macrophage-like cell line. Anticancer Res. 22:53-58; 2002.
33. Hendrich, A. B.; Malon, R.; Pola, A.; Shirataki, Y.; Motohashi, N.; Michalak, K. Differential interaction of Sophora isoflavonoids with lipid bilayers. Eur. J. Pharmeceut. Sci. 16:201-208; 2002.
34. Hooijberg, J. H.; Pinedo, H. M.; Vrasdonk, C.; Priebe, W.; Lankelma, J.; Broxterman, H. J. The effect of glutathione on the ATPase activity of MRP1 in its natural membranes. FEBS Lett. 469:47-51; 2000.
35. Hooijberg, J. H.; Broxterman, H. J.; Heijn, M.; Fles, D. L.; Lankelma, J.; Pinedo, H. M. Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein. FEBS Lett. 413:344-348; 1997.
36. Versantvoort, C. H.; Broxterman, H. J.; Lankelma, J.; Feller, N.; Pinedo, H. M. Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem. Pharmacol. 48:1129-1136; 1994.
37. Versantvoort, C. H.; Rhodes, T.; Twentyman, P. R. Acceleration of MRP-associated efflux of rhodamine 123 by genistein and related compounds. Br. J. Cancer 74:1949-1954; 1996.
38. Bagrij, T.; Klokouzas, A.; Hladky, S. B.; Barrand, M. A. Influences of glutathione on anionic substrate efflux in tumour cells expressing the multidrug resistance-associated protein. MRP1. Biochem. Pharmacol. 62:199-206; 2001.
39. Versantvoort, C. H.; Schuurhuis, G. J.; Pinedo, H. M.; Eekman, C. A.; Kuiper, C. M.; Lankelma, J.; Broxterman, H. J. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Br. J. Cancer 68:939-946; 1993.
40. Liao, K-L.; Yin, M-C. Individual and combined antioxidant effects of seven phenolic agents in human erythrocyte membrane ghosts and phopshatidylcholine liposome systems: Importance of the partition coefficient. J. Agric. Food Chem. 48:2266-2270; 2000.
41. Ollila, F.; Halling, K.; Vuorela, P.; Vuorela, H.; Slotte, J. P. Characterization of flavonoid-biomembrane interactions. Arch. Biochem. Biophys. 399:103-108; 2002.
42. Versantvoort, C. H.; Bagrij, T.; Wright, K. A.; Twentyman, P. R. On the relationship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP). Int. J. Cancer 63:855-862; 1995.
43. Draper, M. P.; Martell, R. L.; Levy, S. B. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein. Br. J. Cancer 75:810-815; 1997.
44. Decleves, X.; Regina, A.; Laplanche, J. L.; Roux, F.; Boval. B.; Launay, J. M.; Scherrmann, J. M. Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes, J. Neurosci. Res. 60:594-601; 2000.
45. Rychlik, B.; Balcerczyk, A.; Klimczak, A.; Bartosz, G. The role of multidrug resistance protein 1 (MRP1) in transport of fluorescent anions across the human erythrocyte membrane. J. Membr. Biol. (in press).
46. Abraham, E. H.; Shrivastav, B.; Salikhova, A. Y.; Sterling, K. M.; Johnston, N.; Guidotti, G.; Scala, S.; Litman, T.; Chan, K. C.; Arceci, R. J.; Steiglitz, K.; Herscher, L.; Okunieff, P. Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: Functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes. Blood Cells Mol. Dis. 27:181-200; 2001.
47. Jedlitschky, G.; Burchell, B.; Keppler, D. The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J. Biol. Chem. 275:30069-30074; 2000.
48. McAleer, M. A.; Breen, M. A.; White, N. L.; Matthews, N. pABCII (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells. J. Biol. Chem. 274:23541-23548; 1999.
49. Wijnholds, J.; Mol. C. A.; van Deemter, L.; de Haas, M.; Scheffer, G. L. ; Baas, F.; Beijnen, J. H.; Scheper, R. J.; Hatse, S.; De Clercq, E.; Balzarini, J.; Borst, P. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc. Natl. Acad. Sci. USA 97:7476-7481; 2000.